These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39106736)

  • 1. Short term outcome of neonatal venous thromboembolism in anticoagulated versus observed patients.
    Beg KA; Chen S; Makoni M; Khan O
    Thromb Res; 2024 Sep; 241():109098. PubMed ID: 39106736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hospital-sssociated venous thromboembolism in the neonatal intensive care unit.
    Amankwah EK; Atchison CM; Arlikar S; Ayala I; Barrett L; Branchford BR; Streiff M; Takemoto C; Goldenberg NA
    Thromb Res; 2014 Aug; 134(2):305-9. PubMed ID: 24953982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
    Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
    Leeper CM; Vissa M; Cooper JD; Malec LM; Gaines BA
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28067012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium.
    Silvey M; Nguyen ATH; Amankwah EK; McElwaine E; Branchford B; Stillings A; Krava E; Young G; Goldenberg N; Jaffray J
    Thromb Res; 2022 Dec; 220():116-120. PubMed ID: 36334398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
    Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
    Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
    J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism after spontaneous intracerebral hemorrhage and the status quo of anticoagulation in this population: A retrospective casecontrol study from a tertiary hospital in China.
    Dong C; Li Y; Ma Z
    Clin Neurol Neurosurg; 2023 Aug; 231():107839. PubMed ID: 37348314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.
    Llitjos JF; Leclerc M; Chochois C; Monsallier JM; Ramakers M; Auvray M; Merouani K
    J Thromb Haemost; 2020 Jul; 18(7):1743-1746. PubMed ID: 32320517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentasaccharides for the prevention of venous thromboembolism.
    Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six Weeks Versus 3 Months of Anticoagulant Treatment for Pediatric Central Venous Catheter-related Venous Thromboembolism.
    Smith R; Jones S; Newall F
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):518-523. PubMed ID: 28859034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
    Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
    Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs.
    Spyropoulos AC; Ashton V; Chen YW; Wu B; Peterson ED
    Thromb Res; 2019 Oct; 182():159-166. PubMed ID: 31493618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.